Large Europe majorities for assisted suicide: survey












PARIS (Reuters) – Large majorities of west Europeans favor the legalization of assisted suicide, now allowed only in four countries on the continent, according to a new survey.


In almost all the 12 countries polled, three-quarters or more of those responding to questions posed by the Swiss Medical Lawyers Association (SMLA) said people should be able to decide when and how they die.












Two-thirds to three-quarters of them said they could imagine opting for assisted suicide themselves if they suffered from an incurable illness, serious disability or uncontrollable pain.


“In practically all European countries, many signs indicate that the prevailing legal system no longer reflects the will of large parts of the population on this issue,” the SMLA said.


The results of its poll “should allow politicians to take democratic principles into account when considering legislation on these issues,” it added in its introduction to the study.


Assisted suicide is now allowed only in Belgium, Luxembourg, Netherlands and Switzerland. The German government has proposed legalizing it as long as no profit is involved while France is debating whether to allow it.


GERMANS MOST OPEN, GREEKS LEAST WILLING


In both Germany and France, the Roman Catholic and Protestant churches oppose legalizing euthanasia and argue for better palliative care to ease pain for dying patients.


The study was conducted by the Swiss pollster Isopublic in Austria, Britain, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Portugal, Spain and Sweden.


It did not survey the four European countries that allow assisted suicide, or countries in eastern Europe.


Germans were most open to letting people decide when and how they die, with 87 percent supporting the idea, and results slowly descended to Denmark’s 71 percent in 11th place.


Greece was the only exception to this strong support, with only 52 percent backing the idea of allowing assisted suicide.


Spaniards were the most willing to consider asking for help to die, with 78 percent support, followed closely by Germans (77 percent) and the French (75 percent).


In Britain, 71 percent said they might seek assisted suicide while Greece was again the most reluctant with 56 percent saying they might do so.


More than three-quarters of those polled in all countries said only doctors or trained practitioners should perform assisted suicides.


A majority of all respondents said doctors should not lose their licenses if they help a patient die. Results ranged from 84 percent in Britain to 58 percent in Greece.


GERMANS OPPOSE GOVERNMENT BILL


About 30 percent of those polled thought dying patients might occasionally be pressured by relatives or doctors into accepting assisted suicide if it is legalized. Roughly another 30 percent thought this would almost never happen.


In Germany, where the government’s bill is now being debated in parliament, 76 percent said the proposed law was wrong to ban assisted suicide if the doctor is paid for the service.


The bill would not punish those helping patients commit suicide, for example by accompanying them to Switzerland where assisted suicide has been legal since 1942.


A rise in dying foreigners – particularly from Germany, France and Britain – ending their lives there has prompted calls for tighter laws, but Zurich voters rejected in 2010 a proposed ban on what opponents called “suicide tourism”.


In the United States, assisted suicide is allowed in Oregon, Washington and Montana. Massachusetts voters narrowly defeated a proposal to legalize it there this month.


(Reporting by Tom Heneghan; Editing by Mark Heinrich)


Health News Headlines – Yahoo! News


Read More..

Supermarkets pledge prices action













Eight supermarkets have agreed to ensure that special offers and price promotions are fair.












The Office of Fair Trading (OFT) has been investigating the way prices are displayed, advertised and promoted in stores.


It raised concerns about prices being artificially inflated to make later discounts look more attractive.


The major UK supermarkets have now agreed to adopt a set of principles drawn up by the OFT.


They are Tesco, Sainsbury’s, Morrisons, Waitrose, Marks and Spencer, Aldi, the Co-op and Lidl.


Asda, which has not yet signed up, said it was considering the revised code.


In a statement Asda argued that as it aims to keep prices for customers “as low as possible for them week in week out”, a code covering special offer price promotions was not relevant.


Continue reading the main story
  • Product is sold at an inflated price for a limited period at low volume in just a few stores, then rolled out across all stores at the lower price – known as “yo-yo pricing”

  • The “discount” price period lasts much longer than the original higher price period, making the discount price really the normal selling price

  • Using a previous selling price from months ago as a comparison

  • Charging one price in store A, a lower price in store B, then saying “was £x, now £y” when the higher price was never actually charged in store B

  • Saying a product price has been reduced without mentioning that this is only because the package size has shrunk

  • Buy One Get One Free deals where the same volume of the same product can be bought more cheaply in a larger pack

Source: Office of Fair Trading



Clive Maxwell, OFT chief executive, told the BBC: “It is particularly welcome that we’ve reached this agreement at this stage with household budgets under pressure”.


‘Squeezed finances’


The OFT says that “half price” or “was £3, now £2″ offers must be sold at the new discounted price for the same, or less, time than the previously higher price.


This would prevent short-term, artificially inflated prices masking the offer.


Items that suggest they are “better value” because they are in a “bigger pack” must have a comparable product elsewhere in the same store,


“Shoppers should be able to trust that special offers and promotions really are bargains,” said Mr Maxwell.


“Prices and promotions need to be fair and meaningful so shoppers can make the right decisions. Nowhere is this more important than during regular shopping for groceries.


“[This] provides supermarkets with a clear benchmark for how they should be operating so that their food and drink promotions reflect the spirit as well as the letter of the law.”


Richard Lloyd, executive director of consumer group Which?, said: “When household budgets are squeezed and food prices are one of people’s top financial worries, it’s unacceptable that shoppers are confused into thinking that they’re getting a good deal when that might not be the case.


“Regulators should be prepared to take enforcement action against traders found breaking the rules.”


A Which? investigation in May suggested that some customers had been misled by supermarkets over discounts and multi-buy offers.


It analysed more than 700,000 prices and suggested that in some cases “discounts” ran for much longer than the original price. Following that investigation, some supermarkets admitted isolated errors amid a huge volume of pricing.



‘Inconsistency’


Misleading advertising is illegal under the 2008 unfair trading regulations, and the OFT is not making any recommendation that the law should be changed.


The regulator said it did not discover any illegality during its investigation, but did find some “inconsistency” in the way the law was interpreted and applied.


Meanwhile, nearly 40% of fast-moving consumer goods could be on some sort of promotion or discount.


Many of the supermarkets said they were happy to work with the OFT.


“We will continue to ensure that our pricing and promotions are as clear as possible for our customers,” said a spokesman for Sainsbury’s.


The Co-op said: “We understand how important it is for shoppers to be able to easily understand what the promotional offer is, so they can spot the best deal, and we are committed to providing clear and accurate labelling for our customers so they can make informed purchasing decisions.”


Aldi said it supported any initiative that encouraged “transparent pricing and a fair deal for consumers”, although the agreement would have no effect on its own prices.


A Marks and Spencer spokesman said: “It is right that we sign up to these new guidelines.”


BBC News – Business


Read More..

Myanmar cracks down on mine protest; dozens hurt












MONYWA, Myanmar (AP) — Security forces used water cannons and other riot gear Thursday to clear protesters from a copper mine in in northwestern Myanmar, wounding villagers and Buddhist monks just hours before opposition leader Aung San Suu Kyi was to visit the area to hear their grievances.


The crackdown at the Letpadaung mine near the town of Monywa risks becoming a public relations and political fiasco for the reformist government of President Thein Sein, which has been touting its transition to democracy after almost five decades of repressive military rule.












The environmental and social damage allegedly produced by the mine has become a popular cause in activist circles, but was not yet a matter of broad public concern. However, hurting monks — as admired for their social activism as they are revered for their spiritual beliefs — is sure to antagonize many ordinary people, especially as Suu Kyi’s visit highlights the events.


“This is unacceptable,” said Ottama Thara, a 25-year-old monk who was at the protest. “This kind of violence should not happen under a government that says it is committed to democratic reforms.”


According to a nurse at a Monywa hospital, 27 monks and one other person were admitted with burns caused by some sort of projectile that released sparks or embers. Two of the monks with serious injuries were sent for treatment in Mandalay, Myanmar’s second biggest city, a 2 ½ hour drive away. Other evicted protesters gathered at a Buddhist temple about 5 kilometers (3 miles) from the mine’s gates.


Lending further sympathy to the protesters’ cause is whom they are fighting against. The mining operation is a joint venture between a Chinese company and a holding company controlled by Myanmar’s military. Most people remain suspicious of the military, while China is widely seen as having propped up army rule for years, in addition to being an aggressive investor exploiting the country’s many natural resources.


Government officials had publicly stated that the protest risked scaring off foreign investment that is key to building the economy after decades of neglect.


State television had broadcast an announcement Tuesday night that ordered protesters to cease their occupation of the mine by midnight or face legal action. It said operations at the mine had been halted since Nov. 18, after protesters occupied the area.


Some villagers among a claimed 1,000 protesters left the six encampments they had at the mine after the order was issued. But others stayed through Wednesday, including about 100 monks.


Police moved in to disperse them early Thursday.


“Around 2:30 a.m. police announced they would give us five minutes to leave,” said protester Aung Myint Htway, a peanut farmer whose face and body were covered with black patches of burned skin. He said police fired water cannons first and then shot what he and others called flare guns.


“They fired black balls that exploded into fire sparks. They shot about six times. People ran away and they followed us,” he said, still writhing hours later from pain. “It’s very hot.”


Photos of the wounded monks showed they had sustained serious burns on parts of their bodies. It was unclear what sort of weapon caused them.


The protest is the latest major example of increased activism by citizens since the elected government took over last year. Political and economic liberalization under Thein Sein has won praise from Western governments, which have eased sanctions imposed on the previous military government because of its poor record on human and civil rights. However, the military still retains major influence over the government, and some critics fear that democratic gains could easily be rolled back.


In Myanmar’s main city of Yangon, six anti-mine activists who staged a small protest were detained Monday and Tuesday, said one of their colleagues, who asked not to be identified because he did not want to attract attention from the authorities.


Asia News Headlines – Yahoo! News


Read More..

R&B star Mary J. Blige sued for defaulting on $2.2 million loan












(Reuters) – R&B star Mary J. Blige was hit with a lawsuit on Wednesday alleging the Grammy winner and her husband defaulted on a $ 2.2 million bank loan.


According to court documents filed in New York State Supreme Court in Manhattan, Signature Bank is seeking to recoup the original loan plus $ 58,000 in interest.












Blige, 41, who has sold more than 50 million albums worldwide, and her husband Martin Isaacs took out the loan in October 2011 and defaulted in July 2012, the suit alleges.


Blige’s publicist declined comment on the lawsuit. The singer’s attorney did not immediately return a request to comment.


The lawsuit also names Blige’s production company, Mary Jane Productions Inc.


The lawsuit is the latest financial headache for the New York City native. The “Family Affair” singer’s charity, The Mary J. Blige and Steve Stoute Foundation for the Advancement of Women Now Inc, was accused earlier in this year of mishandling funds and cheating scholarship students.


Blige acknowledged the problems in a June interview.


“The lives of young women are at stake,” the singer told Reuters when asked about the allegations. “I feel what they feel. I don’t want them to suffer. I promised them something and I’m gonna deliver. Period.”


(Reporting by Eric Kelsey, editing by Jill Serjeant and Todd Eastham)


Music News Headlines – Yahoo! News


Read More..

FDA advisory panel backs efficacy of J&J TB drug












(Reuters) – An advisory panel to the U.S. Food and Drug Administration on Wednesday voted that data suggest an experimental Johnson & Johnson drug for multidrug-resistant tuberculosis is effective, the drugmaker said.


The medicine, called bedaquiline, is a member of a new class of drugs that target adenosine triphosphate synthase, an enzyme the tuberculosis bacterium needs to generate its energy.












J&J said the panel of outside medical experts, in a vote of 18 to 0, found that trial data support the efficacy of bedaquiline in adults, taken in combination with standard treatments.


In September, the FDA granted priority review of the medicine, based on data from two mid-stage trials that tested it among patients with tuberculosis that is resistant to standard drugs.


J&J is hoping the agency will grant accelerated approval of the drug, on the basis of favorable data from mid-stage trials. The company plans to begin a larger Phase 3 study in the fourth quarter.


In a pair of completed Phase 2 trials, two doses of the medicine were tested for 24 weeks, in combination with standard treatments, followed by continuation of standard therapy for a year to 18 months.


The planned larger trial will involve nine months of treatment with bedaquiline, in combination with standard drugs, compared with standard drugs alone for the same period. The total nine-month treatment period would be far shorter than the current 18- to 24-month treatment period for multidrug-resistant tuberculosis drugs recommended by the World Health Organization, J&J said.


Cowen and Co has forecast peak annual sales of $ 300 million for bedaquiline, which would make it a fairly modest product for the diversified healthcare company.


Multidrug-resistant tuberculosis is caused by strains of the bacterium that have become resistant to at least isoniazid and rifampin, the two most potent drugs for TB.


Resistance to anti-TB drugs can occur when they are misused or mismanaged, for instance when patients don’t complete their full course of treatment or when doctors prescribe the wrong treatment, wrong dose or length of time taking the drugs.


An estimated 8.7 million people in 2011 fell ill with tuberculosis – which is spread by coughing and sneezing — while 1.4 million died from the disease, according to the World Health Organization. About 310,000 cases of multidrug-resistant TB were reported the same year, the organization said, with almost 60 percent in India, China and Russia.


(Reporting by Ransdell Pierson; Editing by Jan Paschal and Carol Bishopric)


Medications/Drugs News Headlines – Yahoo! News


Read More..

The Science Behind Those Obama Campaign E-Mails












One fascination in a presidential race mostly bereft of intrigue was the strange, incessant, and weirdly overfamiliar e-mails that emanated from the Obama campaign. Anyone who shared an address with the campaign soon started receiving messages from Barack Obama with subject lines such as “Join me for dinner?” “It’s officially over,” “It doesn’t have to be this way,” or just “Wow.” Jon Stewart mocked them on the Daily Show. The women’s website the Hairpin likened them to notes from a stalker.


But they worked. Most of the $ 690 million Obama raised online came from fundraising e-mails. During the campaign, Obama’s staff wouldn’t answer questions about them or the alchemy that made them so successful. Now, with the election over, they’re opening the black box.












063bb  405 email49 REV The Science Behind Those Obama Campaign E Mails


The appeals were the product of rigorous experimentation by a large team of analysts. “We did extensive A-B testing not just on the subject lines and the amount of money we would ask people for,” says Amelia Showalter, director of digital analytics, “but on the messages themselves and even the formatting.” The campaign would test multiple drafts and subject lines—often as many as 18 variations—before picking a winner to blast out to tens of millions of subscribers. “When we saw something that really moved the dial, we would adopt it,” says Toby Fallsgraff, the campaign’s e-mail director, who oversaw a staff of 20 writers.


It quickly became clear that a casual tone was usually most effective. “The subject lines that worked best were things you might see in your in-box from other people,” Fallsgraff says. “ ‘Hey’ was probably the best one we had over the duration.” Another blockbuster in June simply read, “I will be outspent.” According to testing data shared with Bloomberg Businessweek, that outperformed 17 other variants and raised more than $ 2.6 million.


Writers, analysts, and managers routinely bet on which lines would perform best and worst. “We were so bad at predicting what would win that it only reinforced the need to constantly keep testing,” says Showalter. “Every time something really ugly won, it would shock me: giant-size fonts for links, plain-text links vs. pretty ‘Donate’ buttons. Eventually we got to thinking, ‘How could we make things even less attractive?’ That’s how we arrived at the ugly yellow highlighting on the sections we wanted to draw people’s eye to.”


Another unexpected hit: profanity. Dropping in mild curse words such as “Hell yeah, I like Obamacare” got big clicks. But these triumphs were fleeting. There was no such thing as the perfect e-mail; every breakthrough had a shelf life. “Eventually the novelty wore off, and we had to go back and retest,” says Showalter.


Fortunately for Obama and all political campaigns that will follow, the tests did yield one major counterintuitive insight: Most people have a nearly limitless capacity for e-mail and won’t unsubscribe no matter how many they’re sent. “At the end, we had 18 or 20 writers going at this stuff for as many hours a day as they could stay awake,” says Fallsgraff. “The data didn’t show any negative consequences to sending more.”


After a pause, he offered a qualification: “We do know that getting all those e-mails in your in-box is at least mildly irritating to some people. Even my father would point that out to me.”


The bottom line: Obama’s e-mail fundraising team tested hundreds of grabby subject lines. The most successful—“Hey”— brought in millions of dollars.


Businessweek.com — Top News


Read More..

US rabbi says jailed American in good health












HAVANA (AP) — A prominent New York rabbi and physician visited an American subcontractor serving a long jail term in Cuba and said the man is in good health, despite his family’s concerns about a growth on his right shoulder.


Rabbi Elie Abadie, who is also a gastroenterologist, told The Associated Press in an exclusive interview following Tuesday’s 2 1/2-hour visit at a military hospital in Havana that he personally examined Alan Gross and received a lengthy briefing from a team of Cuban physicians who have attended him.












He said the 1 1/2-inch growth on Gross’s shoulder appeared to be a non-cancerous hematoma that should clear up by itself.


“Alan Gross does not have any cancerous growth at this time, at least based on the studies I was shown and based on the examination, and I think he understands that also,” Abadie said.


Abadie said the hematoma, basically internal bleeding linked to the rupture of muscle fiber, was likely caused by exercise Gross does in jail. He said the growth ought to eventually disappear on its own.


Gross’s plight has put already chilly relations between Cuba and the United States in a deep freeze. The Maryland native was arrested in December 2009 while on a USAID-funded democracy building program and later sentenced to 15 years in jail for crimes against the state.


He claims he was only trying to help the island’s small Jewish community gain Internet access.


Gross’s health has been an ongoing issue during his incarceration. The 63-year-old, who was obese when arrested, has lost more than 100 pounds while in jail.


Abadie, a rabbi at New York’s Edmund J. Safra Synagogue, said Gross’s weight is appropriate for a man his age and height.


Photos that Abadie and a colleague provided to AP of Tuesday’s meeting with Gross showed him looking thin, but generally appearing to be in good spirits.


In one photo, Gross holds up a handwritten note that says “Hi Mom.”


“He definitely feels strong. He is in good spirits. He feels fit, to quote him, physically. But of course, like any other person who is incarcerated or in prison, he wants to be free. He wants to be able to go back home,” Abadie said.


Gross’s family has repeatedly appealed for his release on humanitarian grounds, noting his health problems and the fact that his adult daughter and elderly mother have both been battling cancer.


Jared Genser, counsel to Alan Gross, said late Tuesday that Rabbi Abadie is not Gross’s physician and he would like an oncologist of his choosing to evaluate him.


“While we are grateful Rabbi Abadie was able to see Alan, we have asked an oncologist to review the test results to determine if they are sufficient to rule out cancer. More importantly, if Alan is so healthy, we cannot understand why the Cuban government has repeatedly denied him an independent medical examination by a doctor of his choosing as is required by international law,” said Genser.


Gross and his wife recently filed a $ 60 million lawsuit against his former Maryland employer and the U.S. government, saying they didn’t adequately train him or disclose risks he was undertaking by doing development work on the Communist-run island.


They filed another lawsuit against an insurance company they say has reneged on commitments to pay compensation in case of his wrongful detention.


Separately, a lawyer for Gross has written the United Nations’ anti-torture expert, saying Cuban officials’ treatment of his client “will surely amount to torture” if he continues to be denied medical care.


Rumors have been swirling in U.S. media that Cuba might soon release Gross as a gesture of good will or in the hopes of winning concessions from the administration of President Barack Obama, but Abadie said that those reports appeared to be false.


“As far as I know there is no truth to it,” he said.


Abadie said he met with senior Cuban officials who expressed their desire to resolve the case “as quickly as possible,” but would not say specifically who he spoke with or what they offered.


“They claim that they are more than willing to sit at the table,” he said.


Cuban officials have strongly implied they hope to trade Gross for five Cuban agents sentenced to long jail terms in the United States, one of whom is already free on bail.


Abadie said Gross made clear that he does not want his case linked to that of the agents, known in Cuba as “The Five Heroes,” because he does not believe he is guilty of espionage.


But Abadie said Gross is hoping for a “constructive and productive” dialogue between U.S. and Cuban officials to resolve his case.


___


Follow Paul Haven on Twitter: http://www.twitter.com/paulhaven.


Latin America News Headlines – Yahoo! News


Read More..

Leads, director of Motown musical visit Hitsville












DETROIT (AP) — The stars of the upcoming Broadway musical about Motown Records have read pretty much every book about and listened to every song from that golden era of American music.


The research only took them so far, so they decided to come and see Hitsville, U.S.A., for themselves.












Brandon Victor Dixon, who portrays the label’s founder, Berry Gordy, and Valisia LeKae, who plays its signature songstress, Diana Ross, visited the Motown Museum on Tuesday, taking a lengthy tour of the two-level home that produced the soundtrack of a generation.


“I’m trying not to get emotional,” LeKae said as she methodically inspected the hundreds of mementos — posters, gold records, clothing and more — on display at the Motown Museum.


LeKae, a Broadway veteran who has appeared in “The Book of Mormon” and “Ragtime” among others, worried about losing her composure when it came time to visit Studio A, the famed space in which Gordy and his army of artists, writers, producers and engineers signed, sealed and delivered hit after hit throughout the 1960s.


And she succeeded, descending a small flight of stairs into the square, smallish room and calmly checking out the famed studio affectionately called the “Snake Pit.” LeKae marveled at an oversized black-and-white snapshot on the wall of Ross singing with a smiling Gordy looking on.


It wasn’t until later, while visiting the home’s upstairs, that LeKae’s emotions kicked in.


Standing underneath the “echo chamber,” a hole cut in the upper level’s ceiling designed to create unique sounds for the recording process, LeKae belted out the first few lines of the Supremes’ “Where Did Our Love Go.”


“Baby, baby / Baby, don’t leave me,” she wailed, before the tears began to well up and she had to stop singing.


“This is, like, amazing,” she said.


LeKae and Dixon, who earned a Tony nomination for his work in “The Color Purple” and bears more than a passing resemblance to a Motown-era Gordy, will be front and center when the show debuts this spring.


“Motown: The Musical” begins its run of preview performances March 11 ahead of the official opening on April 14 at New York’s Lunt-Fontanne Theatre.


That gives Dixon, LeKae, Gordy (who’s producing and writing the book) and director Charles Randolph-Wright four months to bring the show to the stage.


To that end, Randolph-Wright also was at Hitsville on Tuesday, seeing prospective actors during a callback session in Studio A. He’s still looking for understudies and others to play smaller parts.


It wasn’t Randolph-Wright’s first visit to Motown’s birthplace as it was for his two leads, but for the 56-year-old who proclaims that “Motown’s in my DNA,” it was no less special.


“What a joy to be a part of (the Motown) movement and what a responsibility to try and place that in the world,” Randolph-Wright said, sitting on a piano bench in Studio A. “So, I’ve been very careful about trying to do that the right way.”


And he has, working for the past three years on “Motown: The Musical,” holding a nationwide casting call and working with Gordy and the other producers to identify which of the overwhelming number of songs from the Motown catalog to include on stage.


“The show is 15 hours,” Randolph-Wright joked.


The first version had 100 songs in it, he said, and “I wanted every song.”


While he said the show’s decision-makers are still deliberating about which songs make the final cut, one thing is certain about the musical selections: A few numbers in the show will be Gordy originals, written specifically for it.


“It’s so interesting to see him go back to being a songwriter after all these years,” said Randolph-Wright, who described one Gordy-penned song as having “all the textures of what Motown is and was, but it’s new.”


As for the man playing the man, Dixon spent his Tuesday walking through the halls of the Motown Museum, taking in every word tour guide Eric Harp and the other docents offered and, as he put it, “soaking it all in.”


At one point, he kneeled down and softly touched the cushion of a red-orange couch upstairs on which Marvin Gaye would take the occasional slumber.


Dixon burst out laughing, then leaped up and continued the tour.


Asked what was so funny, he quickly responded: “Because Marvin Gaye slept on this couch!”


All three of the Hitsville visitors spoke of their great respect and admiration for Gordy and the history of Motown and how important they felt it was to do it justice on stage.


“There’s an energy here that is palpable still,” Randolph-Wright said. “And it remains in this space. I think more than anything, the second I walked in here, it told me that I have to be honest” in telling the Motown story.


The first time he visited the museum, Randolph-Wright remembered walking into the gift shop, where he “bought everything,” including a Temptations T-shirt that read: “Live It Again.”


“I love that, because that’s what we’re doing,” he said.


___


Online:


http://www.motownthemusical.com


Entertainment News Headlines – Yahoo! News


Read More..

Soy unlikely to help hot flashes












NEW YORK (Reuters Health) – Women who eat a lot of soy-based foods or fiber don’t seem to have fewer menopause symptoms, according to a new study.


The findings add to other studies that have found no benefits from eating extra amounts of soy, a food abundant in dietary estrogen.












“It might be a dead end,” said William Wong, a professor at Baylor College of Medicine who has studied the effects of soy protein on menopause symptoms.


Plant-based estrogens, also called phytoestrogens, are found in foods such as seeds, nuts and soybeans. Their chemical structure is similar to human estrogens.


Hormone replacement therapy, based on estrogen among other hormones, is effective in reducing hot flashes and other menopause symptoms, but carries some risks of heart disease and cancer, a large federally funded study released a decade ago found.


Researchers have been testing whether plant estrogens can offer benefits, perhaps without the risks.


“Many women can’t or don’t want to take hormones,” making dietary estrogen an appealing alternative, said Ellen Gold, the lead author of the study and a professor at the University of California Davis School of Medicine.


But studies on plant estrogens have been mixed.


A review of 17 studies on soy supplements has found that the pills can reduce the frequency and severity of hot flashes, while some individual trials on soy protein pills have found no benefits (see Reuters Health reports of April 27, 2012 http://reut.rs/K95gLr and August 8, 2011 http://reut.rs/prmTwt).


To see if women who choose to eat more phytoestrogens have an easier time through menopause, Gold and her colleagues tracked 1,651 women for 10 years.


At the beginning of the study, none of the women had gone through menopause.


Each year the researchers followed up with them to gather any reports of hot flashes or night sweats, and every few years the women filled out a food survey.


By the end of the study, Gold’s team could find no consistent pattern between the amount of phytoestrogens eaten and how often or how severely women experienced hot flashes and night sweats.


The same was true for how much fiber the women ate.


In some cases, the researchers did see a relationship between one type of dietary estrogen and menopause symptoms, but it didn’t always carry through when they examined women of different ethnicities or looked at different points in time.


Those apparent results, they write in the journal Menopause, may have been due to chance.


Gold said it’s possible that for some subsets of women, plant estrogens might have a benefit, but they weren’t able to tease that out in this study.


“I think the more promising avenue for us in the future is to see if there are some women who might benefit,” she told Reuters Health.


Wong, who was not part of the study, is less optimistic because of the negative results seen in long term studies of women taking soy protein supplements.


“After looking at our own clinical trial data and others, we don’t see it,” he told Reuters Health. “I think we should move on.”


SOURCE: http://bit.ly/Uq77iV Menopause, October 29, 2012.


Seniors/Aging News Headlines – Yahoo! News


Read More..

The Investor Is Fleeing, and Other Market Myths












Our 220-year-old stock market is a powerful assemblage of companies, strategies, directors, flacks, hucksters, and heroes joined by a spirit of capitalism that can marry Taco Bell (YUM) with Doritos.


But why stop at that if you’re the financial services industry? What’s especially great about the market is how nicely it lends itself to marketing razzle-dazzle: “value-add,” as they call it on the Street. How else would a mutual fund industry whose active managers generally lag their market benchmarks still be worth nearly $ 12 trillion?












In his provocative post this week, “Everything You Know About Investing is Wrong,” blogging broker Barry Ritholtz shows us how metrics such as dividend yields, economic growth, the Fed Model, profit margins, and past stock returns—what he calls “the assumed truths of Wall Street”—“fail to withstand close scrutiny as having forecasting value.”


While sipping my annual pre-prandial Thanksgiving Courvoisier, I stumbled on a great piece of similarly demystifying research from Birinyi Associates entitled “Six Myths of the Market.” The firm, which was founded by ex-Salomon Brothers trader Laslzo Birinyi, called the market’s generational bottom in March 2009. Authors Jeffrey Yale Rubin and Kevin Pleines penned the note to take on some generally accepted half-truths of investing.


“With the S&P 500 down 5 percent from its mid-September high,” they write, “the chorus of investors and strategists suggesting that this is the start of something bigger has grown louder. With the decline, some new and some not new ideas are being bounced around in support of the negative case. We thought we would take this opportunity to review the accuracy of some of the arguments for the negative thesis.”


That intro is accompanied by a series of charts that show that the 10 U.S. bull markets since 1962 have experienced no fewer than 95 “corrections” of 5 percent or greater.


The current bull run alone has had 17, so you can understand why investors have bolted the market en masse. Or have they? Let’s start with the most eye-opening Birinyi finding:


Myth: The individual is selling.


Haven’t you heard? Investors, wherever they may be, want no part of this three-and-a-half-year bull market. They got burned in the dot-bomb and in 2008; three times would just be too suckerish. And so money continues to storm out of equity mutual funds—to the tune of $ 97 billion in just the first 10 months of the year, and multiples of that over the past four years.


“However,” notes the Birinyi report, “what most research is missing is the offsetting net inflows into equity ETFs over the same period.” Since March 2009, the authors write, there has been a cumulative net outflow from equity mutual funds of $ 242 billion, but an inflow of $ 270 billion to equity ETFs: “In other words, [investors] have increased their exposure to equities.”


For the first 10 months of 2012, the report says, the offset results in a $ 6 billion net outflow—“a far cry from the figures that are most often cited.” This comes as Vanguard index funds have had a net 2012 inflow of $ 88 billion, and while ETF providers slug it out on fees. So much for “Death of Equities Redux.” Rubin and Pleines accordingly “wonder if investors are not necessarily saying that they disliked stocks as much as they are suggesting they disliked actively managed mutual funds.”


Myth: Tax increases are negative for stocks.


The fiscal cliff is supposed to be Armageddon for the market. There have been no shortage of notes from Wall Street and Washington reminding us of how suddenly increased taxes on dividends and capital gains, paired with investing surcharges and the GDP body-blow of automatic budget cuts, will kill equities.


And yet markets are up nicely year-to-date, and actually not far off their record high. How can traders be so maladroit in their anticipation?


Rubin and Pleines note that while there’s never been such a large one-two punch of spending cuts and tax increases, there have been other instances where capital-gains taxes have increased, and significantly more so than they are set to rise this go-around. “We would caution that this time may be different given the combination of tax increases and spending cuts,” they write, “but in the previous two increases since 1942 in the capital-gains tax rate, the record for stocks is mixed, having rallied once and declined once.” In 1976, markets swooned after the top rate increased from 25 percent to 35 percent; a decade later, they went up after the top bracket increased from 20 percent to 33 percent.


Myth: The market is expensive.


Says the report: “Bears have argued almost since day one that the market is not attractive, and if we look at the ten-year trailing normalized earnings approach (usually associated with Robert Shiller), we should be concerned. First, we are always suspicious of contrived or artificial measures. Why ten years, why not a normal economic growth recession cycle (approximately 61 months) or ‘usual’ bull-bear cycle? Or why ten and not five?”


When Rubin and Pleines use “the conventional approach of market multiples (trailing 12 month earnings),” they calculate the S&P 500 trades at 14.8 times earnings, compared with an 85-year average of 16 times.


“Mr. Shiller’s record,” they add, “is less than compelling. In the March 30, 2009, issue of Forbes he said that his P/E calculation would have to drop another two points before he would buy. Given that the magazine has at least a two-week lead time, it was probably made around the second week of March 15, exactly when the market was hitting its low. Since then the market is up 110 percent.”


Myth: Corporate profits will disappoint.


“This mantra has been a hallmark of the bears for the past three years,” Rubin and Pleines note, “yet each quarter earnings have exceeded forecasts.” They point out how this past quarter’s overly curbed enthusiasm was no different, as analysts were looking for a 2 percent earnings contraction, “but when all was said and done earnings grew at a 4.7 percent pace.”


Rubin and Pleines do concede that earnings estimates for the fourth quarter and next year have been declining, “but given analysts’ track record of forecasting earnings, we are skeptical that this time will be any different.”


Myth: Technology is a canary in the coal mine.


“The 11 percent decline in technology stocks since mid-September has led some to suggest that a steeper decline is imminent for the S&P,” write Rubin and Pleines. After all, Apple (AAPL), the market’s biggest weighting—and (probably) consensus indicator species—recently lost as much as a quarter of its peak value. The reality: The relationship between technology corrections and the broader market is “hardly a strong one.” The report notes that since 1982, technology stocks have had 39 declines of at least 10 percent, while the S&P 500 experienced a 10 percent correction just eight of those 39 times.


For those keeping score at home, the tech-laden Nasdaq would have to rally 70 percent to revisit the bubblicious high it set in early 2000.


Myth: Corporations have been building cash reserves.


A grain of salt for an otherwise bullish research note: The notion that corporations “have excessively high cash positions which will be spent once the fiscal cliff is resolved is not supported by the data.”


There goes one fine meme for us financial journos: record corporate cash, itching for a place to go.


The report’s authors explain that excluding financial companies, balance-sheet cash of the S&P 500 stands at $ 787 billion, which is just below the record $ 819 billion set at the end of last year. But they then present a chart that shows corporations have actually lugged record cash during nearly every quarter since 1990. “Why now,” they ask, “will this be spent after 20+ years of record readings?”


When they adjust cash holdings by company market value, Rubin and Pleines find that cash is in fact not at a record, and has not been for more than three years.


Not that this scuppers Birinyi Associates’ view that the S&P 500 is headed to highs unseen since the mythical era when Lehman and Bear roamed the earth.


Businessweek.com — Top News


Read More..